AMTM vs IONS · rev $14.39B vs rev $514.0M
Amentum Holdings Inc. (AMTM) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Amentum Holdings Inc. (AMTM) is a specialty business services company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported AMTM revenue for 2025-10-03 was $14.39B. Net income was $66.0M. Revenue was up 71.6% from 2024-09-27 to 2025-10-03. AMTM currently screens at market cap $4.87B.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
AMTM currently screens at market cap $4.87B. IONS currently screens at market cap $12.28B.
Not investment advice. Open the AMTM and IONS stock pages for the full models.
Not investment advice.